Silexion Therapeutics Corp

SLXN Nasdaq CIK: 0002022416

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Emerging growth company
State of Incorporation Cayman Islands
Business Address 12 ABBA HILLEL ROAD, RAMAT GAN, L3, 5250606
Mailing Address 12 ABBA HILLEL ROAD, RAMAT GAN, L3, 5250606
Phone 972-8-6286005
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

-$16.52M
Net Income
$7.21M
Total Assets
$6.85M
Total Liabilities
$2.60M
Stockholders' Equity
$5.99M
Cash & Equivalents
$394.94
EPS

Recent SEC Filings

Form Type Date Filed Document
4 Insider stock transaction report March 30, 2026 View on SEC
8-K Current report of material events March 25, 2026 View on SEC
8-K Current report of material events March 24, 2026 View on SEC
8-K Current report of material events March 23, 2026 View on SEC
10-K Annual financial report March 17, 2026 View on SEC
4 Insider stock transaction report February 25, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC
4 Insider stock transaction report February 23, 2026 View on SEC

Insider Trading

SELL 1 insiders 1 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.